Lineage Reports Third Quarter 2021 Financial Results and Highlights Progress From Clinical Cell Therapy Programs
Go back to Lineage Reports Third Quarter 2021 Financial Results and Highlights Progress From Clinical Cell Therapy Programs| (NYSE: LCTX) | Delayed: 1.25 -0.01 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.26 | 52 Week High | $ | |||
| Open | $1.24 | 52 Week Low | $ | |||
| Day High | $1.29 | P/E | N/A | |||
| Day Low | $1.24 | EPS | $ | |||
| Volume | 726,006 | |||||
| (NYSE: LCTX) | Delayed: 1.25 -0.01 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.26 | 52 Week High | $ | |||
| Open | $1.24 | 52 Week Low | $ | |||
| Day High | $1.29 | P/E | N/A | |||
| Day Low | $1.24 | EPS | $ | |||
| Volume | 726,006 | |||||

